×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| FERMENTA BIOTECH LIMITED | NA | NA | NA | NA | 1,060 | 10.2 |
| THEMIS MEDICARE LTD. | 987.54 | -153.74 | 975.78 | -1.67 | 1026 | 34.4 |
| Kwality Pharmaceuticals Limite | NA | NA | NA | NA | 982 | 22.6 |
FERMENTA BIOTECH LIMITED, with Security Code 506414, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 53.8 | 100.6 | 76.8 | 51.3 | 89.4 | 89.7 | 72.7 | 89.5 | 146.3 | 122.0 |
| Expenses | 59.8 | 75.0 | 63.6 | 62.9 | 62.9 | 80.7 | 70.9 | 74.1 | 96.1 | 89.3 |
| Operating Profit | -6.1 | 25.6 | 13.2 | -11.6 | 26.5 | 8.9 | 1.8 | 15.5 | 50.1 | 32.7 |
| OPM % | -11.29% | 25.43% | 17.17% | -22.64% | 29.65% | 9.95% | 2.49% | 17.3% | 34.28% | 26.82% |
| Other Income | -44.6 | -13.9 | 2.1 | -7.0 | 2.6 | 1.5 | 2.6 | 2.9 | 2.2 | 3.9 |
| Interest | 5.2 | 6.3 | 4.8 | 3.7 | 5.2 | 3.4 | 3.4 | 3.7 | 4.1 | 3.0 |
| Depreciation | 6.2 | 5.9 | 5.7 | 5.7 | 6.1 | 6.2 | 5.9 | 5.9 | 5.8 | 5.6 |
| Profit before tax | -17.4 | 14.4 | 4.8 | -19.0 | 17.8 | 0.8 | -4.9 | 8.9 | 42.4 | 28.0 |
| Tax % | -4.9% | 198.5% | 0% | 0% | -34.2% | -999.1% | 0% | -7.9% | -17.5% | 4.6% |
| Net Profit | -58.9 | -1.8 | 4.8 | -28.0 | 11.7 | -7.2 | -4.9 | 8.2 | 35.0 | 29.3 |
| EPS in Rs | -20.44 | -0.61 | 1.66 | -9.69 | 4.05 | -2.51 | -1.68 | 2.81 | 12.05 | 0 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 54.9 | 105.2 | 82.4 | 56.9 | 99.0 | 97.3 | 78.1 | 95.0 | 156.5 | 139.8 |
| Expenses | 64.7 | 85.7 | 71.5 | 70.8 | 73.9 | 91.4 | 77.3 | 76.2 | 103.2 | 102.8 |
| Operating Profit | -9.8 | 19.5 | 10.9 | -13.9 | 25.1 | 6.0 | 0.8 | 18.8 | 53.3 | 37.0 |
| OPM % | -17.92% | 18.56% | 13.26% | -24.46% | 25.38% | 6.14% | 1.03% | 19.76% | 34.05% | 26.46% |
| Other Income | -19.4 | -7.9 | 2.0 | -5.5 | 2.5 | 4.8 | 2.8 | 2.9 | 2.2 | 3.9 |
| Interest | 5.1 | 6.3 | 4.8 | 3.7 | 5.2 | 3.4 | 3.4 | 3.7 | 4.1 | 3.0 |
| Depreciation | 6.3 | 6.2 | 5.9 | 5.9 | 6.4 | 6.5 | 6.1 | 6.1 | 6.1 | 5.9 |
| Profit before tax | -21.3 | 8.2 | 2.2 | -21.6 | 16.1 | 0.9 | -5.9 | 11.8 | 45.3 | 32.0 |
| Tax % | -7.5% | 451% | 0% | 0% | -37.8% | -885.9% | 0% | -5.9% | -16.4% | 4.1% |
| Net Profit | -37.6 | -4.9 | 2.2 | -29.1 | 10.0 | -7.1 | -5.9 | 11.1 | 37.9 | 33.3 |
| EPS in Rs | -12.97 | -1.3 | 0.64 | -9.63 | 3.41 | -2.41 | -2.01 | 3.94 | 12.71 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 35% |
| 5 Years: | -5% |
| 3 Years: | -6% |
| TTM: | 25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 242% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 3% |
| 3 Years: | 13% |
| 1 Year: | 82% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | -4% |
| 3 Years: | -4% |
| TTM: | 24% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 457% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 3% |
| 3 Years: | 13% |
| 1 Year: | 82% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|